secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2021-09-24T23:59:59+00:00
Accession:  0001607062-21-000349
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma secures $1.39M net financing via $1.5M note, settles ChemDiv lawsuit for $800K
--------------------------------------------------------------------------------

- Issued $1.5M promissory note to Coventry Enterprises LLC; net proceeds $1.39M after $75K OID and $35K fees.
- Note carries 5% guaranteed interest, matures July 2022, convertible only upon default.
- Paid $800K to ChemDiv to settle lawsuit; settlement includes release of claims and protects IP.
- CEO David Koos reports progress: current SEC filings, $1.905M licensing revenue in Q2 2021, revived patents.
- Goals include settling all convertible notes, hiring CSO, and seeking OTCQB listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000349/0001607062-21-000349-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706221000349/rgbp092421form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-21-000349

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer